| Benson Benny, PHARMD | |
|
6616 Fm 1488 Rd, 77354, TX 77459 | |
| (936) 321-9870 | |
| Not Available |
| Full Name | Benson Benny |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 6616 Fm 1488 Rd, 77354, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568086585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 66203 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Benson Benny, PHARMD 4922 Cypress Spring Dr, Missouri City, TX 77459-4073 Ph: () - | Benson Benny, PHARMD 6616 Fm 1488 Rd, 77354, TX 77459 Ph: (936) 321-9870 |
News Archive
Stanmore Implants, specialists in the design and manufacture of patient specific and modular orthopaedic implants, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Sculptor Robotic Guidance Arm for precision implant placement in unicompartmental knee surgery, also known as partial knee resurfacing.
In a study to be presented on Feb. 4 in an oral concurrent session at 1:15 p.m. EST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, How to Predict Cesarean Delivery in the Nulliparous Patient: Results from the Prospective Multi-center Genesis Study.
Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.
A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.
Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in experimental efforts to regrow damaged nerves, Johns Hopkins researchers report in a new study.
› Verified 2 days ago